Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Soellner

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
ACS Medicinal Chemistry Letters|June 7, 2023
TMPRSS2 Inhibitor Discovery Facilitated through an Amanda L Peiffer, Julie M Garlick, Yujin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2016
UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast CancerRabia A Gilani, Sameer Phadke, Li Wei Bao, et al.
Cancer Research Communications|June 28, 2023
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response AssessmentAki Morikawa, Jinju Li, Peter Ulintz, et al.
European Urology|August 18, 2024
Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine ResponseNathan M Merrill, Samuel D Kaffenberger, Liwei Bao, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
ACS Medicinal Chemistry Letters|June 7, 2023
TMPRSS2 Inhibitor Discovery Facilitated through an Amanda L Peiffer, Julie M Garlick, Yujin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2016
UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast CancerRabia A Gilani, Sameer Phadke, Li Wei Bao, et al.
Cancer Research Communications|June 28, 2023
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response AssessmentAki Morikawa, Jinju Li, Peter Ulintz, et al.
European Urology|August 18, 2024
Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine ResponseNathan M Merrill, Samuel D Kaffenberger, Liwei Bao, et al.
Pageof 5